NCT00543114 Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL Status TERMINATED Phase PHASE1
NCT00542451 Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer Status COMPLETED Phase PHASE2
NCT00538161 Effect of Low Tidal Volume Ventilation in Improving Oxygenation and Thus Reducing Acute Lung Injury in the Cardiac Surgical Patient Status COMPLETED Phase NA
NCT00533923 Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders Status COMPLETED Phase PHASE2
NCT00525460 Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function Status COMPLETED Phase N/A
NCT00521196 Migraine--Investigational Treatment of Migraine With Noninvasive Brain Stimulation. (tDCS- Migraine) Status COMPLETED Phase NA
NCT00520013 Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors Status COMPLETED Phase PHASE2
NCT00483223 Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response Status COMPLETED Phase PHASE2
NCT00476476 Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar Status COMPLETED Phase PHASE2
NCT00476177 Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant Status COMPLETED Phase PHASE1
NCT00476125 Effects of Dietary Manipulation on Metabolism in Healthy Adults Status COMPLETED Phase NA
NCT00459186 The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00459069 The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT00458653 Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma Status COMPLETED Phase PHASE1